![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 05, 2017 1:11:19 PM
All the best,
Silversmith
Effective October 17, 2016, Sigma Labs, Inc. (“we,” “us,” “our,” “Sigma,” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with two accredited investors (the “Investors”) for the private placement by the Company of Secured Convertibles Notes in the aggregate principal amount of $1,000,000 (the "Notes") and warrants (the "Warrants") to purchase up to 160,000 shares (the "Warrant Shares") of the Company's common stock ("Common Stock") (subject to adjustment in certain circumstances), for aggregate gross proceeds, before expenses, to the Company of $900,000 (the “Financing Transaction”). The closing of the Financing Transaction (the “Closing”) occurred on October 19, 2016.
The Warrants also contain certain adjustments that may be made to the Exercise Price due to future corporate events or otherwise, customary for transactions of this type. In the case of certain fundamental transactions affecting the Company, the holders of the Warrants will have the right to elect a cash payment in exchange for their then outstanding Warrants in an amount equal to the Black-Scholes value of those warrants or the positive difference between the cash per share of Common Stock paid in such fundamental transaction minus the then in effect Exercise Price. The Warrants contain a “cashless exercise” feature that allows the Investors to exercise such Warrants without a cash payment to the Company if, on any exercise date, there is not an effective Registration Statement covering the resale of the Warrant Shares by the Investors.
The payment obligations under the Notes may be accelerated upon certain Events of Default, including, among other things, any uncured breach of the Notes, bankruptcy, the existence of an event of default of the Company on any obligation for the payment of borrowed money in excess of $10,000 which is uncured, if the Common Stock is not eligible for listing or quotation for trading on the OTCQB or a national securities exchange, a "Change of Control Transaction" (as defined in the Notes), or the Company fails to have authorized and reserved the amount of shares designated in Section 4.9 of the Purchase Agreement. Upon an Event of Default, the Investors will have the right to accelerate the due date of the Notes and the Company must pay the Investors an aggregate of 110% of the outstanding balance of the Notes, accrued interest and any other sums provided for under the Notes.
END.
Recent SASI News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 03/06/2024 02:09:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 10:11:48 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/12/2024 02:01:27 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 02/09/2024 10:30:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 01:25:51 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/30/2024 11:12:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:45:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:15:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/16/2024 09:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 01:32:12 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/10/2024 09:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 10:00:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 01:39:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 01:38:26 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 01:30:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:20:32 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/07/2023 01:35:07 PM
- Sigma Additive Solutions Announces Filing of Definitive Proxy Statement Relating to Proposed Acquisition and Shareholder Vote • Business Wire • 12/07/2023 01:31:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/01/2023 11:03:17 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:05:37 PM
FEATURED Element79 Gold Corp Appoints Warren Levy to Board of Directors • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM